DYRK
Mammalian DYRKs are a subfamily of mitogen-activated protein kinase-related protein kinases and are originally discovered on the basis of homology to the Saccharomyces cerevisiae Yak1 and Drosophila mini-brain kinases. DYRKs possess Ser/Thr phosphorylation activity as well as autophosphorylation activity on Tyr residue(s).
Two isoforms of DYRK, DYRK1A and DYRK1B, co-immunoprecipitate with HAN11 when coexpressed in COS cells indicating that the proteins interact in mammalian cells. Co-expression of DYRK1A, DYRK1B, or DYRK2 with a series of glycogen synthase mutants with Ser/Ala substitutions at the phosphorylation sites in COS cells revealed that protein kinases cause phosphorylation of site 3a in glycogen synthase. Control of glycogen synthase by DYRK represents a novel mechanism, and a potentially novel pathway, for the regulation of glycogen synthesis.
Targets for DYRK
Products for DYRK
- Cat.No. Product Name Information
-
GC74261
(R)-(+)-O-Demethylbuchenavianine
(R)-(+)-O-Demetlbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK).
-
GC74165
4-(Trifluoromethyl)aniline-d4
4-Aminobenzotrifluoride-d4
4-(Trifluorometl)aniline-d4 is deuterium labeled 4-(Trifluorometl)aniline. -
GC70625
AnnH31
AnnH31 is a Dyrk1A inhibitor (IC50: 81 nM).
-
GC50221
AZ Dyrk1B 33
Potent and selective Dyrk1B kinase inhibitor
-
GC17654
AZ191
DYRK1B inhibitor,potent and selective
-
GC72982
BT173
BT173 is a potent homeodomain interacting protein kinase 2 (HIPK2) inhibitor.
-
GC39485
CK2/ERK8-IN-1
A dual inhibitor of CK2 and ERK8
-
GC73224
CLK1-IN-3
CLK1-IN-3 (compound 10ad) is a potent and selective Clk1 inhibitor, with an IC50 of 5 nM and over 300-fold selectivity for Dyrk1A.
-
GC62946
DYRK1-IN-1
DYRK1-IN-1 is a highly selective and ligand-efficient DYRK1A inhibitor.
-
GC70985
Dyrk1A-IN-3
Dyrk1A-IN-3 (Compound 8b), a highly selective dual-specificity tyrosine-regulated kinase 1A (DYRK1A)inhibitor, maintains high levels of DYRK1A binding affinity (IC50=76 nM).
-
GC69031
Dyrk1A-IN-5
Dyrk1A-IN-5 (compound 5j) is a potent and selective inhibitor of DYRK1A with an IC50 value of 6 nM. Dyrk1A-IN-5 dose-dependently reduces the phosphorylation of Thr434 in SF3B1, with an IC50 of 0.5 μM. Dyrk1A-IN-5 inhibits the phosphorylation of tau protein at Thr212, with an IC50 of 2.1 μM. Dyrk1A-IN-5 can be used for research on Down syndrome.
-
GC62947
DYRKs-IN-1 hydrochloride
DYRKs-IN-1 hydrochloride is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 5 nM and 8 nM for DYRK1A and DYRK1B, respectively. DYRKs-IN-1 hydrochloride has antitumor activity.
-
GC38330
EHT 5372
-
GC71197
FINDY
FINDY is a folding intermediate-selective inhibitor of DYRK1A.
-
GC64724
GNF2133
GNF2133 is a potent, selective and orally active DYRK1A inhibitor with IC50s of 0.0062, >50 ?M for DYRK1A and GSK3β, respectively.
-
GC64725
GNF2133 hydrochloride
GNF2133 hydrochloride is a potent, selective and orally active DYRK1A inhibitor with IC50s of 0.0062, >50 ?M for DYRK1A and GSK3β, respectively.
-
GC38787
GNF4877
GNF4877 is a potent DYRK1A and GSK3β inhibitor with IC50s of 6?nM and 16?nM, respectively, which leads to blockade of nuclear factor of activated T-cells (NFATc) nuclear export and increased β-cell proliferation (EC50 of 0.66?μM for mouse β (R7T1) cells).
-
GC36194
GSK-626616
GSK-626616 is a potent, orally bioavailable inhibitor of DYRK3 (IC50=0.7 nM).
-
GC30762
Harmine (Telepathine)
A unique regulator of PPARγ expression
-
GC38413
Harmine hydrochloride
-
GC72931
HTH-01-091 TFA
HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM.
-
GC15647
ID-8
DYRK inhibitor
-
GC16126
INDY
Dyrk1A and Dyrk1B inhibitor, selective
-
GC63943
KH-CB20
KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4, with an IC50 of 16.5 nM for CLK1.
-
GC33086
LDN-192960
LDN-192960 is an inhibitor of Haspin and Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) with IC50s of 10 nM and 48 nM, respectively.
-
GC44047
LDN-192960 (hydrochloride)
LDN-192960 is an inhibitor of haspin protein kinase and dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) with IC50 values of 10 and 48 nM, respectively.
-
GC32819
Mirk-IN-1 (Dyrk1B/A-IN-1)
Dyrk1B/A-IN-1
Mirk-IN-1 (Dyrk1B/A-IN-1) is a potent inhibitor of Dyrk1B(Mirk kianse) and Dyrk1A with IC50 of 68±48 nM and 22±8 nM respectively. -
GC73707
ON 108600
ON 108600 is a inhibitor for CK2 (Casein Kinase2)/TNIK/DYRK1 , with the IC50s for DYRK1A/DYRKB, DYRK2, CK2α1/CK2α2, and TNIK of 0.016 μm/0.007 μM, 0.028 μM, 0.05 μM/0.005 μM, and 0.005 μM, respectively.
-
GC69769
Protein kinase inhibitor 1 hydrochloride
Protein kinase inhibitor 1 hydrochloride is an effective inhibitor of HIPK2, with IC50 values of 136 and 74 nM for HIPK1 and HIPK2 respectively, and a Kd value of 9.5 nM for HIPK2.
-
GC34131
Protein kinase inhibitors 1
Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
-
GC61217
Protein kinase inhibitors 1 hydrochloride
Protein kinase inhibitors 1 hydrochloride is a potent HIPK2 inhibitor, with IC50s of 136 and 74 nM for HIPK1 and HIPK2, and a Kd of 9.5 nM for HIPK2.
-
GC65395
T025
T025 is an orally active and highly potent inhibitor of Cdc2-like kinase (CLKs), with Kd values of 4.8, 0.096, 6.5, 0.61, 0.074, 1.5 and 32 nM for CLK1, CLK2, CLK3, CLK4, DYRK1A, DYRK1B and DYRK2, respectively.
-
GC37746
tBID
tBID is a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2) with an IC50 of ?0.33 ?M.